Structure-activity studies of quinolone-penems in genetically defined strains of Escherichia coli

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 11, 1997, Pages 2570-2572

  Ehrhardt, Anton F ^a   Sanders, Christine C ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOSUFLOXACIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG STRUCTURE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; STRUCTURE ACTIVITY RELATION;

EID: 0030664631     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.11.2570     Document Type: Article

References (13)

1. Albrecht, H. A., G. Beskid, K. K. Chan, J. G. Christenson, R. Cleeland, K. H. Deitcher, N. H. Georgopapadakou, D. D. Keith, D. L. Pruess, and J. Sepinwall. 1990. Cephalosporin 3′-quinolone esters with a dual mode of action. J. Med. Chem. 33:77-86.
2. Albrecht, H. A., G. Beskid, J. G. Christenson, K. H. Deitcher, N. H. Georgopapadakou, D. D. Keith, F. M. Konzelmann, D. L. Pruess, and C. C. Wei. 1994. Dual-action cephalosporins incorporating a 3′-tertiary-amine-linked quinolone. J. Med. Chem. 37:400-407.
3. Ames, G. F. 1972. Resolution of bacterial proteins by polyacrylamide gel electrophoresis on slabs. Membrane, soluble, and periplasmic fractions. J. Biol. Chem. 249:634-644.
4. Ehrhardt, A. F., and C. C. Sanders. 1992. Structure/activity studies of quinolonyl β-lactam antimicrobials (QLA) using a genetically defined panel, abstr. 771, p. 239. In Program and Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
5. Georgopapadakou, N. H., and A. Bertasso. 1993. Mechanisms of action of cephalosporin 3′-quinolone esters, carbamates, and tertiary amines in Escherichia coli. Antimicrob. Agents Chemother. 37:559-565.
6. Hooper, D. C., and J. S. Wolfson. 1993. Mechanisms of bacterial resistance to quinolones, p. 97-118. In D. C. Hooper and J. S. Wolfson (ed.), Quinolone antimicrobial agents, 2nd ed. American Society for Microbiology, Washington, D.C.
7. Jones, R. N. 1990. In vitro activity of Ro 24-6392, a novel ester-linked co-drug combining ciprofloxacin and desacetylcefotaxime. Eur. J. Clin. Microbiol. Infect. Dis. 9:435-438.
8. Keith, D. D., H. A. Albrecht, G. Beskid, K. K. Chan, J. G. Christenson, R. Cleeland, K. Deitcher, M. Delaney, N. H. Georgopapadakou, F. Konzelmann, M. Okabe, D. Pruess, P. Rossman, A. Specian, R. Then, C. C. Wei, and M. Weigele. 1993. Mechanism-based dual-action cephalosporins, p. 79-92. In P. H. Bentley and R. Ponsford (ed.), Recent advances in the chemistry of anti-infective agents. Royal Society of Chemistry, Cambridge, United Kingdom.
9. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual, p. 368-369. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
10. National Committee for Clinical Laboratory Standards. 1991. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A2. National Committee for Clinical Laboratory Standards, Villanova, Pa.
11. Nikaido, H. 1992. Porins and specific channels of bacterial outer membranes. Mol. Microbiol. 6:435-442.
12. Rourke, F. J., B. W. Davis, W. G. Kraft, R. E. White, C. C. McOsker, M. A. Walling, J. A. Andersen, A. M. Salvagno, P. M. Fitzpatrick, L. A. Jamieson, and T. P. Demuth, Jr. 1992. Evaluation of new quinolonyl penem carbamates, abstr. 772, p. 239. In Program and Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
13. Rourke, F. J., B. W. Davis, W. G. Kraft, R. E. White, C. C. McOsker, T. L. O'Hara, and T. P. Demuth, Jr. 1993. In vitro activities of two new quinolonylpenem carbamates, abstr. 1489, p. 391. In Program and Abstracts of the 33rd International Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.